121 related articles for article (PubMed ID: 1384340)
1. Enhanced tenascin expression in cervical and vulvar koilocytotic lesions.
Tiitta O; Wahlström T; Paavonen J; Linnala A; Sharma S; Gould VE; Virtanen I
Am J Pathol; 1992 Oct; 141(4):907-13. PubMed ID: 1384340
[TBL] [Abstract][Full Text] [Related]
2. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast.
Howeedy AA; Virtanen I; Laitinen L; Gould NS; Koukoulis GK; Gould VE
Lab Invest; 1990 Dec; 63(6):798-806. PubMed ID: 1701508
[TBL] [Abstract][Full Text] [Related]
3. Distribution of tenascin, cellular fibronectins and integrins in the normal, hyperplastic and neoplastic breast.
Koukoulis GK; Howeedy AA; Korhonen M; Virtanen I; Gould VE
J Submicrosc Cytol Pathol; 1993 Apr; 25(2):285-95. PubMed ID: 7686813
[TBL] [Abstract][Full Text] [Related]
4. Differential distribution of tenascin and cellular fibronectins in acute and chronic renal allograft rejection.
Gould VE; Martinez-Lacabe V; Virtanen I; Sahlin KM; Schwartz MM
Lab Invest; 1992 Jul; 67(1):71-9. PubMed ID: 1378105
[TBL] [Abstract][Full Text] [Related]
5. Expression of tenascin in human cervical cancer--association of tenascin expression with clinicopathological parameters.
Pilch H; Schäffer U; Schlenger K; Lautz A; Tanner B; Höckel M; Knapstein PG
Gynecol Oncol; 1999 Jun; 73(3):415-21. PubMed ID: 10366470
[TBL] [Abstract][Full Text] [Related]
6. Expression of p53 protein related to the presence of human papillomavirus (HPV) DNA in genital carcinomas and precancer lesions.
Tervahauta AI; Syrjänen SM; Väyrynen M; Saastamoinen J; Syrjänen KJ
Anticancer Res; 1993; 13(4):1107-11. PubMed ID: 8394670
[TBL] [Abstract][Full Text] [Related]
7. Tenascin expression in the human endometrium and in endometrial adenocarcinomas.
Vollmer G; Siegal GP; Chiquet-Ehrismann R; Lightner VA; Arnholdt H; Knuppen R
Lab Invest; 1990 Jun; 62(6):725-30. PubMed ID: 1694256
[TBL] [Abstract][Full Text] [Related]
8. Detection of human papillomavirus in cervical smears. A comparison of in situ hybridization, immunocytochemistry and cytopathology.
Gupta JW; Gupta PK; Rosenshein N; Shah KV
Acta Cytol; 1987; 31(4):387-96. PubMed ID: 3037829
[TBL] [Abstract][Full Text] [Related]
9. Tenascin in preinvasive lesions of the vulva and vulvar cancer.
Goepel C; Stoerer S; Koelbl H
Anticancer Res; 2003; 23(6C):4587-91. PubMed ID: 14981900
[TBL] [Abstract][Full Text] [Related]
10. Tenascin expression in normal and abnormal human endometrium.
Sasano H; Nagura H; Watanabe K; Ito K; Tsuiki A; Sato S; Yajima A; Kusakabe M; Sakakura T
Mod Pathol; 1993 May; 6(3):323-6. PubMed ID: 7688462
[TBL] [Abstract][Full Text] [Related]
11. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
12. [Detection of HPV-DNA in the various uterocervical lesions by in situ hybridization].
Ishi K; Kina K; Kawashima T; Shimota H; Utsuno H; Takada M
Rinsho Byori; 1989 Nov; 37(11):1284-8. PubMed ID: 2557468
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of multiple types of human papillomavirus in genital tract lesions. Analysis by in situ hybridization and the polymerase chain reaction.
Nuovo GJ; Darfler MM; Impraim CC; Bromley SE
Am J Pathol; 1991 Jan; 138(1):53-8. PubMed ID: 1846265
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus (HPV) infection of cervical lesions detected by immunohistochemistry and in situ hybridization.
Hoepfner I; Löning T
Cancer Detect Prev; 1986; 9(3-4):293-301. PubMed ID: 3017555
[TBL] [Abstract][Full Text] [Related]
15. Cytologic and histologic manifestations of human papillomavirus infection of the uterine cervix.
Koss LG
Cancer Detect Prev; 1990; 14(4):461-4. PubMed ID: 2171769
[TBL] [Abstract][Full Text] [Related]
16. Tenascin distribution in basal cell carcinomas.
Stamp GW
J Pathol; 1989 Nov; 159(3):225-9. PubMed ID: 2480437
[TBL] [Abstract][Full Text] [Related]
17. Morphometric assessment of the biological potential of human papillomavirus infections in the uterine cervix.
Tosi P; Luzi P; Santopietro R; Miracco C; Lio R; Syrjänen S; Mäntyjärvi R; Syrjänen K
Appl Pathol; 1988; 6(4):247-57. PubMed ID: 2846018
[TBL] [Abstract][Full Text] [Related]
18. Detection of human papillomavirus DNA sequences in cervical lesions by in situ hybridization using biotinylated DNA probes.
Zhang ZS; Wu YL; Xu LL; Yang YH
Chin Med J (Engl); 1992 Apr; 105(4):293-7. PubMed ID: 1319885
[TBL] [Abstract][Full Text] [Related]
19. Detection of human papillomavirus in normal and dysplastic tissue by the polymerase chain reaction.
Shibata D; Fu YS; Gupta JW; Shah KV; Arnheim N; Martin WJ
Lab Invest; 1988 Oct; 59(4):555-9. PubMed ID: 2845193
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of alpha-dystroglycan in cervical and vulvar cancer.
Sgambato A; Tarquini E; Resci F; De Paola B; Faraglia B; Camerini A; Rettino A; Migaldi M; Cittadini A; Zannoni GF
Gynecol Oncol; 2006 Nov; 103(2):397-404. PubMed ID: 16765426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
